트랜스펙션 기술 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 트랜스펙션 방법별, 제품별, 용도별, 기술별, 지역별, 경쟁별 세분화(2020-2030년)
Transfection Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Transfection Method, By Product, By Applications, By Technology, By Region, and By Competition, 2020-2030F
상품코드:1886278
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 182 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 트랜스펙션 기술 시장은 2024년에 30억 3,000만 달러로 평가되며, 2030년까지 CAGR 9.61%로 성장하며, 52억 5,000만 달러에 달할 것으로 예측됩니다. 트랜스펙션 기술이란 DNA, RNA 등의 외래 핵산을 진핵세포에 도입하는 기술을 말하며, 다양한 연구, 치료, 바이오 생산 용도로 유전자 변형을 가능하게 합니다. 시장 성장은 주로 생명과학 연구에 대한 전 세계 대규모 투자, 유전자 및 세포치료에 대한 수요 증가, 백신 개발의 진전, 기능유전체학 연구의 확대 등 효율적인 핵산 도입이 필요한 요인에 의해 주도되고 있습니다.
시장 개요
예측 기간
2026-2030
시장 규모 : 2024년
30억 3,000만 달러
시장 규모 : 2030년
52억 5,000만 달러
CAGR : 2025-2030년
9.61%
가장 빠르게 성장하는 부문
리포펙션
최대 시장
북미
주요 시장 성장 촉진요인
세계 트랜스펙션 기술 시장은 두 가지 주요 요인에 의해 크게 영향을 받고 있습니다. 하나는 세포 및 유전자 치료에 대한 수요 증가, 다른 하나는 세포 및 유전자 치료에 대한 수요 증가, 그리고 트랜스펙션 기법 및 전달 시스템의 지속적인 기술 발전입니다. 세포 및 유전자 치료제 파이프라인이 확대됨에 따라 이러한 첨단 치료제의 연구개발 및 상용화에 필수적인 강력하고 효율적인 핵산 전달 툴이 직접적으로 요구되고 있습니다.
주요 시장 과제
시장 확대를 가로막는 가장 큰 문제는 특정 트랜스펙션 방법에 내재된 세포 독성과 효율의 편차가 존재한다는 점입니다. 이러한 문제는 세포의 생존율과 분석의 재현성을 직접적으로 손상시키고, 실험 실패 증가, 연구개발 기간의 장기화, 고가의 시약과 인건비의 막대한 낭비를 초래합니다.
주요 시장 동향
첨단 유전자 편집 기술과의 통합은 단순한 유전물질의 도입을 넘어 세포내 정밀하고 표적화된 유전체 변형을 가능하게 하는 트랜스펙션의 중요한 진화를 의미합니다. CRISPR-Cas 시스템과 같은 첨단 유전자 편집 툴을 효과적으로 도입하는 것은 새로운 치료 응용 및 기능 유전체학 연구를 가속화하는 데 매우 중요합니다.
용도별(바이러스 생산, 단백질 생산, 유전자 침묵, 줄기세포 재프로그램화 및 분화, 안정 세포주 생성, 치료제 전달, 생물의학 연구, 기타)
기술별(물리적 트랜스펙션, 생화학적 트랜스펙션, 바이러스 벡터 기반 트랜스펙션)
지역별
기업별(2024)
시장 맵
제6장 북미의 트랜스펙션 기술 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 트랜스펙션 기술 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 트랜스펙션 기술 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 트랜스펙션 기술 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 트랜스펙션 기술 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 트랜스펙션 기술 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Promega Corporation
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Roche Molecular Systems, Inc.
QIAGEN NV
Inovio Pharmaceuticals
Mirus Bio LLC
Takara Bio Inc.
SignaGen Laboratories
MaxCyte, Inc.
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Transfection Technologies Market, valued at USD 3.03 Billion in 2024, is projected to experience a CAGR of 9.61% to reach USD 5.25 Billion by 2030. Transfection technologies encompass methods for introducing exogenous nucleic acids, such as DNA or RNA, into eukaryotic cells, enabling genetic modification for various research, therapeutic, and bioproduction applications. The market's growth is primarily driven by substantial global investments in life sciences research, escalating demand for gene and cell therapies, advancements in vaccine development, and expanding functional genomics initiatives, all requiring efficient nucleic acid delivery.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 3.03 Billion
Market Size 2030
USD 5.25 Billion
CAGR 2025-2030
9.61%
Fastest Growing Segment
Lipofection
Largest Market
North America
Key Market Drivers
The Global Transfection Technologies Market is significantly influenced by two critical factors: the growing demand for cell and gene therapies and continuous technological advancements in transfection methods and delivery systems. The expanding pipeline of cell and gene therapies directly necessitates robust and efficient nucleic acid delivery tools, crucial for the research, development, and eventual commercialization of these advanced therapeutic products.
Key Market Challenges
A significant challenge impeding market expansion stems from the inherent cytotoxicity and variable efficiency associated with certain transfection methods. These issues directly compromise cell viability and assay reproducibility, leading to increased experimental failures, extended research and development timelines, and substantial wastage of costly reagents and labor. Compromised cell viability necessitates repeated experiments, driving up operational expenditures for biopharmaceutical companies engaged in drug discovery and therapeutic development. Similarly, inconsistent transfection efficiency results in unreliable data, requiring extensive validation and re-evaluation, thereby slowing the progression of promising candidates from preclinical stages to clinical trials.
Key Market Trends
The integration with advanced gene editing technologies represents a pivotal evolution in transfection, moving beyond mere genetic material introduction to enabling precise and targeted genomic modifications within cells. The effective delivery of advanced gene editing tools, such as CRISPR-Cas systems, by transfection methods is instrumental in accelerating research for novel therapeutic applications and functional genomics. This integration facilitates the correction of specific disease-causing mutations and precise modulation of gene expression. The expanded utility in these highly targeted applications amplifies the demand for sophisticated delivery systems that ensure high efficiency, cell viability, and minimal off-target effects.
Key Market Players
Promega Corporation
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Roche Molecular Systems, Inc.
QIAGEN NV
Inovio Pharmaceuticals
Mirus Bio LLC
Takara Bio Inc.
SignaGen Laboratories
MaxCyte, Inc.
Report Scope:
In this report, the Global Transfection Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Transfection Technologies Market, By Transfection Method:
Cotransfection
Electroporation
Cationic Lipid Transfection
Lipofection
Nucleofection
In Vivo Transfection
Transfection Technologies Market, By Product:
Reagent
Instrument
Others
Transfection Technologies Market, By Application:
Virus Production
Protein Production
Gene Silencing
Stem Cell Reprogramming and Differentiation
Stable Cell Line Generation
Therapeutic Delivery
Bio-Medical Research
Others
Transfection Technologies Market, By Technology:
Physical Transfection
Biochemical Based Transfection
Viral-Vector Based Transfection
Transfection Technologies Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Transfection Technologies Market.
Available Customizations:
Global Transfection Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Transfection Technologies Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Transfection Method (Cotransfection, Electroporation, Cationic Lipid Transfection, Lipofection, Nucleofection, In Vivo Transfection)
5.2.2. By Product (Reagent, Instrument, Others)
5.2.3. By Application (Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming and Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Bio-Medical Research, Others)
5.2.4. By Technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Transfection Technologies Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Transfection Method
6.2.2. By Product
6.2.3. By Application
6.2.4. By Technology
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Transfection Technologies Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Transfection Method
6.3.1.2.2. By Product
6.3.1.2.3. By Application
6.3.1.2.4. By Technology
6.3.2. Canada Transfection Technologies Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Transfection Method
6.3.2.2.2. By Product
6.3.2.2.3. By Application
6.3.2.2.4. By Technology
6.3.3. Mexico Transfection Technologies Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Transfection Method
6.3.3.2.2. By Product
6.3.3.2.3. By Application
6.3.3.2.4. By Technology
7. Europe Transfection Technologies Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Transfection Method
7.2.2. By Product
7.2.3. By Application
7.2.4. By Technology
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Transfection Technologies Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Transfection Method
7.3.1.2.2. By Product
7.3.1.2.3. By Application
7.3.1.2.4. By Technology
7.3.2. France Transfection Technologies Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Transfection Method
7.3.2.2.2. By Product
7.3.2.2.3. By Application
7.3.2.2.4. By Technology
7.3.3. United Kingdom Transfection Technologies Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Transfection Method
7.3.3.2.2. By Product
7.3.3.2.3. By Application
7.3.3.2.4. By Technology
7.3.4. Italy Transfection Technologies Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Transfection Method
7.3.4.2.2. By Product
7.3.4.2.3. By Application
7.3.4.2.4. By Technology
7.3.5. Spain Transfection Technologies Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Transfection Method
7.3.5.2.2. By Product
7.3.5.2.3. By Application
7.3.5.2.4. By Technology
8. Asia Pacific Transfection Technologies Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Transfection Method
8.2.2. By Product
8.2.3. By Application
8.2.4. By Technology
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Transfection Technologies Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Transfection Method
8.3.1.2.2. By Product
8.3.1.2.3. By Application
8.3.1.2.4. By Technology
8.3.2. India Transfection Technologies Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Transfection Method
8.3.2.2.2. By Product
8.3.2.2.3. By Application
8.3.2.2.4. By Technology
8.3.3. Japan Transfection Technologies Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Transfection Method
8.3.3.2.2. By Product
8.3.3.2.3. By Application
8.3.3.2.4. By Technology
8.3.4. South Korea Transfection Technologies Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Transfection Method
8.3.4.2.2. By Product
8.3.4.2.3. By Application
8.3.4.2.4. By Technology
8.3.5. Australia Transfection Technologies Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Transfection Method
8.3.5.2.2. By Product
8.3.5.2.3. By Application
8.3.5.2.4. By Technology
9. Middle East & Africa Transfection Technologies Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Transfection Method
9.2.2. By Product
9.2.3. By Application
9.2.4. By Technology
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Transfection Technologies Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Transfection Method
9.3.1.2.2. By Product
9.3.1.2.3. By Application
9.3.1.2.4. By Technology
9.3.2. UAE Transfection Technologies Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Transfection Method
9.3.2.2.2. By Product
9.3.2.2.3. By Application
9.3.2.2.4. By Technology
9.3.3. South Africa Transfection Technologies Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Transfection Method
9.3.3.2.2. By Product
9.3.3.2.3. By Application
9.3.3.2.4. By Technology
10. South America Transfection Technologies Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Transfection Method
10.2.2. By Product
10.2.3. By Application
10.2.4. By Technology
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Transfection Technologies Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Transfection Method
10.3.1.2.2. By Product
10.3.1.2.3. By Application
10.3.1.2.4. By Technology
10.3.2. Colombia Transfection Technologies Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Transfection Method
10.3.2.2.2. By Product
10.3.2.2.3. By Application
10.3.2.2.4. By Technology
10.3.3. Argentina Transfection Technologies Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Transfection Method
10.3.3.2.2. By Product
10.3.3.2.3. By Application
10.3.3.2.4. By Technology
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Transfection Technologies Market: SWOT Analysis
